Today's Date: March 28, 2024
KFC TAKES FINGER LICKIN' GOOD TO A WHOLE NEW LEVEL WITH NEW SAUCY NUGGETS IN FIVE DRIPPING FLAVORS   •   Contentful Studio Launches, Transforming Digital Team Efficiency While Shortening Time-to-Impact From Months to Minutes   •   Phone Fraud and Spam Reached All-Time High, Costing Scammed Consumers Nearly $2,300 on Average in 2023   •   Cisco Sponsors SANS Institute Cohort to Close Cybersecurity Skills Gap   •   Tigo Energy Headquarters Receives 90kW of Optimized Solar from Long-Time Installer Partner   •   Oka, The Carbon Insurance Company (Oka)™ Closes $10-Million in Funding   •   Tetra Tech to Host Inaugural Investor Day on May 14, 2024   •   Dexian Invests in Tomorrow’s Tech Leaders   •   Milliken & Company Receives A- Climate Change Performance Rating   •   Grundfos Revolutionizes Wastewater Management with Metasphere Smart Water Sensors   •   Wolters Kluwer enters nursing test prep market with launch of Lippincott Ready for NCLEX   •   Meijer Continues Fight Against Hunger with $2 Million Donation to Midwest Food Bank Partners   •   The Pershing Square Foundation Announces $2M in Grants to Newark Organizations to Support Local Community   •   Zuniga Health's 'Elevate' health plans fit the needs for Hispanic small businesses   •   Courageous Parents' Dr. Chrissy Chard to Lead a TEDx Talk on Transformative Discipline Practices   •   Ready. Set. Food! and ObvioHealth Launch Innovative Trial to Correlate Infant Food Allergy Prevention with Reduced Healthcare Co   •   Displate Introduces Textra, A Metal Poster Bringing Art to Life in 3D   •   WellSky® Develops New Clinical Care Certification to Enhance Expertise and Competency in Home Healthcare   •   Health Care Costs Top the List of Financial Worries in Retirement, New Research from eHealth and Retirable Shows   •   Headlands Research Announces Fifth Research Site under Partnership with Pfizer to Improve Diversity in Clinical Trials
Bookmark and Share

Volpara Showcases Intelligent Breast Cancer Screening Platform at AHRA

Volpara Showcases Intelligent Breast Cancer Screening Platform at AHRA

VolparaPlatform Optimizes and Personalizes Patient Screening Pathways

PR Newswire

WELLINGTON, New Zealand, Aug. 10, 2020 /PRNewswire/ -- Volpara Solutions will spotlight the Volpara®Platform™, a comprehensive suite of artificial intelligence and software tools that improve breast cancer detection, at the Association for Medical Imaging Management (AHRA) 2020 virtual conference on August 11-13.

The VolparaPlatform clinical decision support tools enable radiologists to make informed and timely decisions about a patient's need for supplemental imaging and/or genetic testing as part of personalized breast care. Volpara®Scorecard+™ software provides three key patient risk insights, including:

  • Breast density. Volpara®Density software uses artificial intelligence (AI), physics and imaging data to provide radiologists with an automated, objective, volumetric breast density assessment.
  • Short-term risk. Transpara® software by ScreenPoint Medical uses AI to automatically assign each screening mammogram a score from 1 to 10. Exams with a high score are more likely to contain breast cancer.
  • Lifetime risk. Volpara®Risk™ software captures patient information through a simple, easy-to-use interface. VolparaRisk uses that information, along with the VolparaDensity score, to calculate a woman's lifetime risk of developing breast cancer using the Tyrer-Cuzick Breast Cancer Risk model (TC8).

"Our vision is to offer each woman a personalized screening regimen for the earliest detection of breast cancer based on her breast density, risk factors and hereditary testing. Using Volpara's AI-driven, automated breast density to implement a risk-stratified screening program, we have seen tremendous compliance to screening schedules," reports Leigh Loughran, Operations Manager Medical Imaging at Rome Memorial Hospital, Rome, New York.

In addition to Scorecard, VolparaPlatform supports clinics with continuous image quality improvement and workflow productivity tools. These include:

  • Volpara®Live!TM software analyzes ideal patient positioning, radiation dose and compression in real time to provide actionable feedback. If needed, the technologist can use the recommendations to retake the image immediately, to ensure image quality and to reduce call backs.



  • Volpara®Enterprise™ software provides a full view of productivity at the technologist, room, department, and enterprise level. This includes tracking the number of studies per day, time of day, and study duration per room. The software also calculates and monitors the dose delivered to patients to ensure that the equipment is performing safely.



  • Aspen® Breast mammography reporting and patient tracking software streamlines workflow by customizing reports and patient letters to include the radiologist's recommendations based on imaging studies and the results of breast cancer risk models including TC8.  Aspen Breast now provides the option of generating medical necessity letters for insurance pre-authorizations for supplemental screening and testing procedures.

"Healthcare is always going to be a human-centered business. Our goal is to mesh the best of technology with the best of human." said Dr. Lloyd McCann, CEO, Mercy Radiology, Auckland, New Zealand. "We want to enable our providers with the best technology so they can spend more time connecting with patients."

About Volpara Solutions

Volpara's advanced technology platform combines with the healthcare provider's expertise to provide a high-quality, optimized, and personalized cancer screening experience. From the time a patient enters a clinic to the moment they obtain key results, our platform collects and analyzes information to better understand a patient's breast cancer risk, while also objectively evaluating image quality and workflow-improvement opportunities. These capabilities are being extended to lung cancer screening. The VolparaPlatform is supported by numerous patents, trademarks, and regulatory registrations, including FDA clearance and CE marking, and validated by a volume of peer-reviewed publications unrivaled in the breast screening industry. For more information, visit http://www.volparasolutions.com.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/volpara-showcases-intelligent-breast-cancer-screening-platform-at-ahra-301108910.html

SOURCE Volpara Solutions



Back to top
| Back to home page
Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News